163 related articles for article (PubMed ID: 20607367)
1. Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.
Kim HA; Lim S; Moon HH; Kim SW; Hwang KC; Lee M; Kim SH; Choi D
Pharm Res; 2010 Oct; 27(10):2075-84. PubMed ID: 20607367
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of erythropoietin enhancer-mediated hypoxia-inducible gene expression by co-transfection of a plasmid encoding hypoxia-inducible factor 1alpha for ischemic tissue targeting gene therapy.
Lee S; Kim K; Kim HA; Kim SW; Lee M
J Drug Target; 2008 Jan; 16(1):43-50. PubMed ID: 18172819
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW
Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
[TBL] [Abstract][Full Text] [Related]
6. Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy.
Jin H; Liu ML; Kim HA; Lee M; An S; Oh J; Cho J; Yi S; Kim K; Yoon D; Ha Y
Spine (Phila Pa 1976); 2009 Dec; 34(26):E952-8. PubMed ID: 20010384
[TBL] [Abstract][Full Text] [Related]
7. Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia.
Won YW; McGinn AN; Lee M; Nam K; Bull DA; Kim SW
Biomaterials; 2013 Aug; 34(26):6229-38. PubMed ID: 23714244
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.
Ryu JK; Lee M; Choi MJ; Kim HA; Jin HR; Kim WJ; Yin GN; Song KM; Kwon MH; Suh JK
J Androl; 2012; 33(5):845-53. PubMed ID: 22403284
[TBL] [Abstract][Full Text] [Related]
9. Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion.
Won YW; Lee M; Kim HA; Bull DA; Kim SW
J Control Release; 2012 Jun; 160(3):525-31. PubMed ID: 22450332
[TBL] [Abstract][Full Text] [Related]
10. Post-translational regulation of gene expression using the ATF4 oxygen-dependent degradation domain for hypoxia-specific gene therapy.
Cho SH; Oh B; Kim HA; Park JH; Lee M
J Drug Target; 2013 Nov; 21(9):830-6. PubMed ID: 23952904
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
Koshikawa N; Takenaga K
Cancer Res; 2005 Dec; 65(24):11622-30. PubMed ID: 16357173
[TBL] [Abstract][Full Text] [Related]
12. Neural stem cells modified by a hypoxia-inducible VEGF gene expression system improve cell viability under hypoxic conditions and spinal cord injury.
Lian Jin H; Pennant WA; Hyung Lee M; Su S; Ah Kim H; Lu Liu M; Soo Oh J; Cho J; Nyun Kim K; Heum Yoon D; Ha Y
Spine (Phila Pa 1976); 2011 May; 36(11):857-64. PubMed ID: 21192293
[TBL] [Abstract][Full Text] [Related]
13. Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease.
Lee M; Bikram M; Oh S; Bull DA; Kim SW
Pharm Res; 2004 May; 21(5):736-41. PubMed ID: 15180327
[TBL] [Abstract][Full Text] [Related]
14. Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery.
Christensen LV; Chang CW; Yockman JW; Conners R; Jackson H; Zhong Z; Feijen J; Bull DA; Kim SW
J Control Release; 2007 Apr; 118(2):254-61. PubMed ID: 17276536
[TBL] [Abstract][Full Text] [Related]
15. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
Choi M; Oh J; Rhim T; Lee M
Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
[TBL] [Abstract][Full Text] [Related]
16. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain.
Kim HA; Kim K; Kim SW; Lee M
J Control Release; 2007 Aug; 121(3):218-24. PubMed ID: 17628167
[TBL] [Abstract][Full Text] [Related]
18. [Effect of nanoparticle with vascular endothelial growth factor gene transferred into ischemic myocardium: experiment with rabbits].
Yi F; Wu H; Jia GL; Guo WY; Lü AL; Wang HC; Zhang RQ
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):510-4. PubMed ID: 16681877
[TBL] [Abstract][Full Text] [Related]
19. Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system.
Lee M; Lee ES; Kim YS; Choi BH; Park SR; Park HS; Park HC; Kim SW; Ha Y
Spine (Phila Pa 1976); 2005 Dec; 30(24):2729-34. PubMed ID: 16371895
[TBL] [Abstract][Full Text] [Related]
20. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
Kim HA; Park JH; Yi N; Lee M
Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
